Global Enzyme-Linked Immunosorbent Assay (ELISA) Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global Enzyme-Linked Immunosorbent Assay (ELISA) Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 100

Published Date: 06 Jun 2021

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The Enzyme-Linked Immunosorbent Assay (ELISA) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Enzyme-Linked Immunosorbent Assay (ELISA) size is estimated to be USD 213.3 million in 2026 from USD 186.2 million in 2020, with a change XX% between 2020 and 2021. The global Enzyme-Linked Immunosorbent Assay (ELISA) market size is expected to grow at a CAGR of 3.4% for the next five years.

Market segmentation
Enzyme-Linked Immunosorbent Assay (ELISA) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Sandwich ELISA
Indirect ELISA
Competitive ELISA
Others

Market segment by Application, can be divided into
Immunology
Inflammation
Infectious Diseases
Cancer
Protein Quantitation
Others

Market segment by players, this report covers
R&D Systems
Thermo Fisher Scientific
Ortho Clinical Diagnostics
BD Biosciences
ZEUS Scientific
Bio-Rad Laboratories
ALPCO
Enzo Life Sciences
BioMérieux
EMD Millipore
BioLegend
LOEWE Biochemica
Mercodia
Cusabio
Shanghai Kehua Bio-engineering

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Enzyme-Linked Immunosorbent Assay (ELISA) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Enzyme-Linked Immunosorbent Assay (ELISA), with revenue, gross margin and global market share of Enzyme-Linked Immunosorbent Assay (ELISA) from 2019 to 2021.
Chapter 3, the Enzyme-Linked Immunosorbent Assay (ELISA) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Enzyme-Linked Immunosorbent Assay (ELISA) market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Enzyme-Linked Immunosorbent Assay (ELISA) research findings and conclusion, appendix and data source.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Enzyme-Linked Immunosorbent Assay (ELISA)
1.2 Classification of Enzyme-Linked Immunosorbent Assay (ELISA) by Type
1.2.1 Overview: Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Type in 2020
1.2.3 Sandwich ELISA
1.2.4 Indirect ELISA
1.2.5 Competitive ELISA
1.2.6 Others
1.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market by Application
1.3.1 Overview: Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Immunology
1.3.3 Inflammation
1.3.4 Infectious Diseases
1.3.5 Cancer
1.3.6 Protein Quantitation
1.3.7 Others
1.4 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size & Forecast
1.5 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast by Region
1.5.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Region, (2016-2021)
1.5.3 North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Prospect (2016-2026)
1.5.4 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Prospect (2016-2026)
1.5.6 South America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Enzyme-Linked Immunosorbent Assay (ELISA) Market Drivers
1.6.2 Enzyme-Linked Immunosorbent Assay (ELISA) Market Restraints
1.6.3 Enzyme-Linked Immunosorbent Assay (ELISA) Trends Analysis

2 Company Profiles
2.1 R&D Systems
2.1.1 R&D Systems Details
2.1.2 R&D Systems Major Business
2.1.3 R&D Systems Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.1.4 R&D Systems Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 R&D Systems Recent Developments and Future Plans
2.2 Thermo Fisher Scientific
2.2.1 Thermo Fisher Scientific Details
2.2.2 Thermo Fisher Scientific Major Business
2.2.3 Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.2.4 Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.3 Ortho Clinical Diagnostics
2.3.1 Ortho Clinical Diagnostics Details
2.3.2 Ortho Clinical Diagnostics Major Business
2.3.3 Ortho Clinical Diagnostics Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.3.4 Ortho Clinical Diagnostics Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Ortho Clinical Diagnostics Recent Developments and Future Plans
2.4 BD Biosciences
2.4.1 BD Biosciences Details
2.4.2 BD Biosciences Major Business
2.4.3 BD Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.4.4 BD Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 BD Biosciences Recent Developments and Future Plans
2.5 ZEUS Scientific
2.5.1 ZEUS Scientific Details
2.5.2 ZEUS Scientific Major Business
2.5.3 ZEUS Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.5.4 ZEUS Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 ZEUS Scientific Recent Developments and Future Plans
2.6 Bio-Rad Laboratories
2.6.1 Bio-Rad Laboratories Details
2.6.2 Bio-Rad Laboratories Major Business
2.6.3 Bio-Rad Laboratories Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.6.4 Bio-Rad Laboratories Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.7 ALPCO
2.7.1 ALPCO Details
2.7.2 ALPCO Major Business
2.7.3 ALPCO Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.7.4 ALPCO Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 ALPCO Recent Developments and Future Plans
2.8 Enzo Life Sciences
2.8.1 Enzo Life Sciences Details
2.8.2 Enzo Life Sciences Major Business
2.8.3 Enzo Life Sciences Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.8.4 Enzo Life Sciences Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Enzo Life Sciences Recent Developments and Future Plans
2.9 BioMérieux
2.9.1 BioMérieux Details
2.9.2 BioMérieux Major Business
2.9.3 BioMérieux Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.9.4 BioMérieux Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 BioMérieux Recent Developments and Future Plans
2.10 EMD Millipore
2.10.1 EMD Millipore Details
2.10.2 EMD Millipore Major Business
2.10.3 EMD Millipore Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.10.4 EMD Millipore Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 EMD Millipore Recent Developments and Future Plans
2.11 BioLegend
2.11.1 BioLegend Details
2.11.2 BioLegend Major Business
2.11.3 BioLegend Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.11.4 BioLegend Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 BioLegend Recent Developments and Future Plans
2.12 LOEWE Biochemica
2.12.1 LOEWE Biochemica Details
2.12.2 LOEWE Biochemica Major Business
2.12.3 LOEWE Biochemica Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.12.4 LOEWE Biochemica Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 LOEWE Biochemica Recent Developments and Future Plans
2.13 Mercodia
2.13.1 Mercodia Details
2.13.2 Mercodia Major Business
2.13.3 Mercodia Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.13.4 Mercodia Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Mercodia Recent Developments and Future Plans
2.14 Cusabio
2.14.1 Cusabio Details
2.14.2 Cusabio Major Business
2.14.3 Cusabio Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.14.4 Cusabio Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Cusabio Recent Developments and Future Plans
2.15 Shanghai Kehua Bio-engineering
2.15.1 Shanghai Kehua Bio-engineering Details
2.15.2 Shanghai Kehua Bio-engineering Major Business
2.15.3 Shanghai Kehua Bio-engineering Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.15.4 Shanghai Kehua Bio-engineering Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Shanghai Kehua Bio-engineering Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Enzyme-Linked Immunosorbent Assay (ELISA) Players Market Share
3.2.2 Top 10 Enzyme-Linked Immunosorbent Assay (ELISA) Players Market Share
3.2.3 Market Competition Trend
3.3 Enzyme-Linked Immunosorbent Assay (ELISA) Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
4.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Market Share by Type (2016-2021)
4.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
5.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Application (2016-2021)
5.2 Enzyme-Linked Immunosorbent Assay (ELISA) Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
6.1 North America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Type (2016-2026)
6.2 North America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Application (2016-2026)
6.3 North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country
6.3.1 North America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Country (2016-2026)
6.3.2 United States Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)
6.3.3 Canada Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)
6.3.4 Mexico Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
7.1 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Type (2016-2026)
7.2 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Application (2016-2026)
7.3 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country
7.3.1 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Country (2016-2026)
7.3.2 Germany Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)
7.3.3 France Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)
7.3.5 Russia Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)
7.3.6 Italy Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Type (2016-2026)
8.2 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Application (2016-2026)
8.3 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Region
8.3.1 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Region (2016-2026)
8.3.2 China Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)
8.3.3 Japan Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)
8.3.4 South Korea Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)
8.3.5 India Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)
8.3.7 Australia Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
9.1 South America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Type (2016-2026)
9.2 South America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Application (2016-2026)
9.3 South America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country
9.3.1 South America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Country (2016-2026)
9.3.2 Brazil Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)
9.3.3 Argentina Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Type (2016-2026)
10.2 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Application (2016-2026)
10.3 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country
10.3.1 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Country (2016-2026)
10.3.2 Turkey Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)
10.3.4 UAE Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million) by Region (2016-2021)
Table 5. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Region (2021-2026)
Table 6. R&D Systems Corporate Information, Head Office, and Major Competitors
Table 7. R&D Systems Major Business
Table 8. R&D Systems Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 9. R&D Systems Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 11. Thermo Fisher Scientific Major Business
Table 12. Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 13. Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Ortho Clinical Diagnostics Corporate Information, Head Office, and Major Competitors
Table 15. Ortho Clinical Diagnostics Major Business
Table 16. Ortho Clinical Diagnostics Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 17. Ortho Clinical Diagnostics Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. BD Biosciences Corporate Information, Head Office, and Major Competitors
Table 19. BD Biosciences Major Business
Table 20. BD Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 21. BD Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. ZEUS Scientific Corporate Information, Head Office, and Major Competitors
Table 23. ZEUS Scientific Major Business
Table 24. ZEUS Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 25. ZEUS Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors
Table 27. Bio-Rad Laboratories Major Business
Table 28. Bio-Rad Laboratories Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 29. Bio-Rad Laboratories Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. ALPCO Corporate Information, Head Office, and Major Competitors
Table 31. ALPCO Major Business
Table 32. ALPCO Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 33. ALPCO Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Enzo Life Sciences Corporate Information, Head Office, and Major Competitors
Table 35. Enzo Life Sciences Major Business
Table 36. Enzo Life Sciences Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 37. Enzo Life Sciences Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. BioMérieux Corporate Information, Head Office, and Major Competitors
Table 39. BioMérieux Major Business
Table 40. BioMérieux Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 41. BioMérieux Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. EMD Millipore Corporate Information, Head Office, and Major Competitors
Table 43. EMD Millipore Major Business
Table 44. EMD Millipore Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 45. EMD Millipore Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. BioLegend Corporate Information, Head Office, and Major Competitors
Table 47. BioLegend Major Business
Table 48. BioLegend Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 49. BioLegend Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. LOEWE Biochemica Corporate Information, Head Office, and Major Competitors
Table 51. LOEWE Biochemica Major Business
Table 52. LOEWE Biochemica Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 53. LOEWE Biochemica Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Mercodia Corporate Information, Head Office, and Major Competitors
Table 55. Mercodia Major Business
Table 56. Mercodia Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 57. Mercodia Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Cusabio Corporate Information, Head Office, and Major Competitors
Table 59. Cusabio Major Business
Table 60. Cusabio Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 61. Cusabio Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Shanghai Kehua Bio-engineering Corporate Information, Head Office, and Major Competitors
Table 63. Shanghai Kehua Bio-engineering Major Business
Table 64. Shanghai Kehua Bio-engineering Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 65. Shanghai Kehua Bio-engineering Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million) by Players (2019-2021)
Table 67. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Share by Players (2019-2021)
Table 68. Breakdown of Enzyme-Linked Immunosorbent Assay (ELISA) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 69. Enzyme-Linked Immunosorbent Assay (ELISA) Players Head Office, Products and Services Provided
Table 70. Enzyme-Linked Immunosorbent Assay (ELISA) Mergers & Acquisitions in the Past Five Years
Table 71. Enzyme-Linked Immunosorbent Assay (ELISA) New Entrants and Expansion Plans
Table 72. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million) by Type (2016-2021)
Table 73. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Share by Type (2016-2021)
Table 74. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Forecast by Type (2021-2026)
Table 75. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Application (2016-2021)
Table 76. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Forecast by Application (2021-2026)
Table 77. North America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Type (2016-2021) & (USD Million)
Table 78. North America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Type (2021-2026) & (USD Million)
Table 79. North America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Application (2016-2021) & (USD Million)
Table 80. North America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Application (2021-2026) & (USD Million)
Table 81. North America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Country (2016-2021) & (USD Million)
Table 82. North America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Country (2021-2026) & (USD Million)
Table 83. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Type (2016-2021) & (USD Million)
Table 84. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Type (2021-2026) & (USD Million)
Table 85. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Application (2016-2021) & (USD Million)
Table 86. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Application (2021-2026) & (USD Million)
Table 87. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Country (2016-2021) & (USD Million)
Table 88. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Country (2021-2026) & (USD Million)
Table 89. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Type (2016-2021) & (USD Million)
Table 90. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Type (2021-2026) & (USD Million)
Table 91. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Application (2016-2021) & (USD Million)
Table 92. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Application (2021-2026) & (USD Million)
Table 93. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Region (2016-2021) & (USD Million)
Table 94. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Region (2021-2026) & (USD Million)
Table 95. South America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Type (2016-2021) & (USD Million)
Table 96. South America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Type (2021-2026) & (USD Million)
Table 97. South America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Application (2016-2021) & (USD Million)
Table 98. South America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Application (2021-2026) & (USD Million)
Table 99. South America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Country (2016-2021) & (USD Million)
Table 100. South America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Country (2021-2026) & (USD Million)
Table 101. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Type (2016-2021) & (USD Million)
Table 102. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Type (2021-2026) & (USD Million)
Table 103. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Application (2016-2021) & (USD Million)
Table 104. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Application (2021-2026) & (USD Million)
Table 105. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Country (2016-2021) & (USD Million)
Table 106. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Enzyme-Linked Immunosorbent Assay (ELISA) Picture
Figure 2. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Type in 2020
Figure 3. Sandwich ELISA
Figure 4. Indirect ELISA
Figure 5. Competitive ELISA
Figure 6. Others
Figure 7. Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Application in 2020
Figure 8. Immunology Picture
Figure 9. Inflammation Picture
Figure 10. Infectious Diseases Picture
Figure 11. Cancer Picture
Figure 12. Protein Quantitation Picture
Figure 13. Others Picture
Figure 14. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 15. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Forecast (2016-2026) & (USD Million)
Figure 16. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Region (2016-2026)
Figure 17. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Region in 2020
Figure 18. North America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. South America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Middle East and Africa Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. Enzyme-Linked Immunosorbent Assay (ELISA) Market Drivers
Figure 24. Enzyme-Linked Immunosorbent Assay (ELISA) Market Restraints
Figure 25. Enzyme-Linked Immunosorbent Assay (ELISA) Market Trends
Figure 26. R&D Systems Recent Developments and Future Plans
Figure 27. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 28. Ortho Clinical Diagnostics Recent Developments and Future Plans
Figure 29. BD Biosciences Recent Developments and Future Plans
Figure 30. ZEUS Scientific Recent Developments and Future Plans
Figure 31. Bio-Rad Laboratories Recent Developments and Future Plans
Figure 32. ALPCO Recent Developments and Future Plans
Figure 33. Enzo Life Sciences Recent Developments and Future Plans
Figure 34. BioMérieux Recent Developments and Future Plans
Figure 35. EMD Millipore Recent Developments and Future Plans
Figure 36. BioLegend Recent Developments and Future Plans
Figure 37. LOEWE Biochemica Recent Developments and Future Plans
Figure 38. Mercodia Recent Developments and Future Plans
Figure 39. Cusabio Recent Developments and Future Plans
Figure 40. Shanghai Kehua Bio-engineering Recent Developments and Future Plans
Figure 41. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Share by Players in 2020
Figure 42. Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 43. Global Top 3 Players Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share in 2020
Figure 44. Global Top 10 Players Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share in 2020
Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 46. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Share by Type in 2020
Figure 47. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Share Forecast by Type (2021-2026)
Figure 48. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Share by Application in 2020
Figure 49. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Share Forecast by Application (2021-2026)
Figure 50. North America Enzyme-Linked Immunosorbent Assay (ELISA) Sales Market Share by Type (2016-2026)
Figure 51. North America Enzyme-Linked Immunosorbent Assay (ELISA) Sales Market Share by Application (2016-2026)
Figure 52. North America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Country (2016-2026)
Figure 53. United States Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Canada Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Mexico Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Sales Market Share by Type (2016-2026)
Figure 57. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Sales Market Share by Application (2016-2026)
Figure 58. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Country (2016-2026)
Figure 59. Germany Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. France Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. United Kingdom Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Russia Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Italy Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Sales Market Share by Type (2016-2026)
Figure 65. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Sales Market Share by Application (2016-2026)
Figure 66. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Region (2016-2026)
Figure 67. China Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Japan Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. South Korea Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. India Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Southeast Asia Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Australia Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. South America Enzyme-Linked Immunosorbent Assay (ELISA) Sales Market Share by Type (2016-2026)
Figure 74. South America Enzyme-Linked Immunosorbent Assay (ELISA) Sales Market Share by Application (2016-2026)
Figure 75. South America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Country (2016-2026)
Figure 76. Brazil Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Argentina Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Middle East and Africa Enzyme-Linked Immunosorbent Assay (ELISA) Sales Market Share by Type (2016-2026)
Figure 79. Middle East and Africa Enzyme-Linked Immunosorbent Assay (ELISA) Sales Market Share by Application (2016-2026)
Figure 80. Middle East and Africa Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Country (2016-2026)
Figure 81. Turkey Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Saudi Arabia Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. UAE Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. Methodology
Figure 85. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

R&D Systems
Thermo Fisher Scientific
Ortho Clinical Diagnostics
BD Biosciences
ZEUS Scientific
Bio-Rad Laboratories
ALPCO
Enzo Life Sciences
BioMérieux
EMD Millipore
BioLegend
LOEWE Biochemica
Mercodia
Cusabio
Shanghai Kehua Bio-engineering
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Enzyme-Linked Immunosorbent Assay (ELISA) Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global Enzyme-Linked Immunosorbent Assay (ELISA) Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 100

Published Date: 06 Jun 2021

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The Enzyme-Linked Immunosorbent Assay (ELISA) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Enzyme-Linked Immunosorbent Assay (ELISA) size is estimated to be USD 213.3 million in 2026 from USD 186.2 million in 2020, with a change XX% between 2020 and 2021. The global Enzyme-Linked Immunosorbent Assay (ELISA) market size is expected to grow at a CAGR of 3.4% for the next five years.

Market segmentation
Enzyme-Linked Immunosorbent Assay (ELISA) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Sandwich ELISA
Indirect ELISA
Competitive ELISA
Others

Market segment by Application, can be divided into
Immunology
Inflammation
Infectious Diseases
Cancer
Protein Quantitation
Others

Market segment by players, this report covers
R&D Systems
Thermo Fisher Scientific
Ortho Clinical Diagnostics
BD Biosciences
ZEUS Scientific
Bio-Rad Laboratories
ALPCO
Enzo Life Sciences
BioMérieux
EMD Millipore
BioLegend
LOEWE Biochemica
Mercodia
Cusabio
Shanghai Kehua Bio-engineering

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Enzyme-Linked Immunosorbent Assay (ELISA) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Enzyme-Linked Immunosorbent Assay (ELISA), with revenue, gross margin and global market share of Enzyme-Linked Immunosorbent Assay (ELISA) from 2019 to 2021.
Chapter 3, the Enzyme-Linked Immunosorbent Assay (ELISA) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Enzyme-Linked Immunosorbent Assay (ELISA) market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Enzyme-Linked Immunosorbent Assay (ELISA) research findings and conclusion, appendix and data source.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Enzyme-Linked Immunosorbent Assay (ELISA)
1.2 Classification of Enzyme-Linked Immunosorbent Assay (ELISA) by Type
1.2.1 Overview: Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Type in 2020
1.2.3 Sandwich ELISA
1.2.4 Indirect ELISA
1.2.5 Competitive ELISA
1.2.6 Others
1.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market by Application
1.3.1 Overview: Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Immunology
1.3.3 Inflammation
1.3.4 Infectious Diseases
1.3.5 Cancer
1.3.6 Protein Quantitation
1.3.7 Others
1.4 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size & Forecast
1.5 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast by Region
1.5.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Region, (2016-2021)
1.5.3 North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Prospect (2016-2026)
1.5.4 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Prospect (2016-2026)
1.5.6 South America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Enzyme-Linked Immunosorbent Assay (ELISA) Market Drivers
1.6.2 Enzyme-Linked Immunosorbent Assay (ELISA) Market Restraints
1.6.3 Enzyme-Linked Immunosorbent Assay (ELISA) Trends Analysis

2 Company Profiles
2.1 R&D Systems
2.1.1 R&D Systems Details
2.1.2 R&D Systems Major Business
2.1.3 R&D Systems Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.1.4 R&D Systems Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 R&D Systems Recent Developments and Future Plans
2.2 Thermo Fisher Scientific
2.2.1 Thermo Fisher Scientific Details
2.2.2 Thermo Fisher Scientific Major Business
2.2.3 Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.2.4 Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.3 Ortho Clinical Diagnostics
2.3.1 Ortho Clinical Diagnostics Details
2.3.2 Ortho Clinical Diagnostics Major Business
2.3.3 Ortho Clinical Diagnostics Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.3.4 Ortho Clinical Diagnostics Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Ortho Clinical Diagnostics Recent Developments and Future Plans
2.4 BD Biosciences
2.4.1 BD Biosciences Details
2.4.2 BD Biosciences Major Business
2.4.3 BD Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.4.4 BD Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 BD Biosciences Recent Developments and Future Plans
2.5 ZEUS Scientific
2.5.1 ZEUS Scientific Details
2.5.2 ZEUS Scientific Major Business
2.5.3 ZEUS Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.5.4 ZEUS Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 ZEUS Scientific Recent Developments and Future Plans
2.6 Bio-Rad Laboratories
2.6.1 Bio-Rad Laboratories Details
2.6.2 Bio-Rad Laboratories Major Business
2.6.3 Bio-Rad Laboratories Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.6.4 Bio-Rad Laboratories Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.7 ALPCO
2.7.1 ALPCO Details
2.7.2 ALPCO Major Business
2.7.3 ALPCO Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.7.4 ALPCO Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 ALPCO Recent Developments and Future Plans
2.8 Enzo Life Sciences
2.8.1 Enzo Life Sciences Details
2.8.2 Enzo Life Sciences Major Business
2.8.3 Enzo Life Sciences Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.8.4 Enzo Life Sciences Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Enzo Life Sciences Recent Developments and Future Plans
2.9 BioMérieux
2.9.1 BioMérieux Details
2.9.2 BioMérieux Major Business
2.9.3 BioMérieux Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.9.4 BioMérieux Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 BioMérieux Recent Developments and Future Plans
2.10 EMD Millipore
2.10.1 EMD Millipore Details
2.10.2 EMD Millipore Major Business
2.10.3 EMD Millipore Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.10.4 EMD Millipore Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 EMD Millipore Recent Developments and Future Plans
2.11 BioLegend
2.11.1 BioLegend Details
2.11.2 BioLegend Major Business
2.11.3 BioLegend Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.11.4 BioLegend Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 BioLegend Recent Developments and Future Plans
2.12 LOEWE Biochemica
2.12.1 LOEWE Biochemica Details
2.12.2 LOEWE Biochemica Major Business
2.12.3 LOEWE Biochemica Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.12.4 LOEWE Biochemica Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 LOEWE Biochemica Recent Developments and Future Plans
2.13 Mercodia
2.13.1 Mercodia Details
2.13.2 Mercodia Major Business
2.13.3 Mercodia Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.13.4 Mercodia Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Mercodia Recent Developments and Future Plans
2.14 Cusabio
2.14.1 Cusabio Details
2.14.2 Cusabio Major Business
2.14.3 Cusabio Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.14.4 Cusabio Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Cusabio Recent Developments and Future Plans
2.15 Shanghai Kehua Bio-engineering
2.15.1 Shanghai Kehua Bio-engineering Details
2.15.2 Shanghai Kehua Bio-engineering Major Business
2.15.3 Shanghai Kehua Bio-engineering Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
2.15.4 Shanghai Kehua Bio-engineering Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Shanghai Kehua Bio-engineering Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Enzyme-Linked Immunosorbent Assay (ELISA) Players Market Share
3.2.2 Top 10 Enzyme-Linked Immunosorbent Assay (ELISA) Players Market Share
3.2.3 Market Competition Trend
3.3 Enzyme-Linked Immunosorbent Assay (ELISA) Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
4.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Market Share by Type (2016-2021)
4.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
5.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Application (2016-2021)
5.2 Enzyme-Linked Immunosorbent Assay (ELISA) Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
6.1 North America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Type (2016-2026)
6.2 North America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Application (2016-2026)
6.3 North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country
6.3.1 North America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Country (2016-2026)
6.3.2 United States Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)
6.3.3 Canada Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)
6.3.4 Mexico Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
7.1 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Type (2016-2026)
7.2 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Application (2016-2026)
7.3 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country
7.3.1 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Country (2016-2026)
7.3.2 Germany Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)
7.3.3 France Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)
7.3.5 Russia Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)
7.3.6 Italy Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Type (2016-2026)
8.2 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Application (2016-2026)
8.3 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Region
8.3.1 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Region (2016-2026)
8.3.2 China Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)
8.3.3 Japan Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)
8.3.4 South Korea Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)
8.3.5 India Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)
8.3.7 Australia Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
9.1 South America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Type (2016-2026)
9.2 South America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Application (2016-2026)
9.3 South America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country
9.3.1 South America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Country (2016-2026)
9.3.2 Brazil Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)
9.3.3 Argentina Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Type (2016-2026)
10.2 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Application (2016-2026)
10.3 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country
10.3.1 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Country (2016-2026)
10.3.2 Turkey Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)
10.3.4 UAE Enzyme-Linked Immunosorbent Assay (ELISA) Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million) by Region (2016-2021)
Table 5. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Region (2021-2026)
Table 6. R&D Systems Corporate Information, Head Office, and Major Competitors
Table 7. R&D Systems Major Business
Table 8. R&D Systems Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 9. R&D Systems Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 11. Thermo Fisher Scientific Major Business
Table 12. Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 13. Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Ortho Clinical Diagnostics Corporate Information, Head Office, and Major Competitors
Table 15. Ortho Clinical Diagnostics Major Business
Table 16. Ortho Clinical Diagnostics Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 17. Ortho Clinical Diagnostics Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. BD Biosciences Corporate Information, Head Office, and Major Competitors
Table 19. BD Biosciences Major Business
Table 20. BD Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 21. BD Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. ZEUS Scientific Corporate Information, Head Office, and Major Competitors
Table 23. ZEUS Scientific Major Business
Table 24. ZEUS Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 25. ZEUS Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors
Table 27. Bio-Rad Laboratories Major Business
Table 28. Bio-Rad Laboratories Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 29. Bio-Rad Laboratories Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. ALPCO Corporate Information, Head Office, and Major Competitors
Table 31. ALPCO Major Business
Table 32. ALPCO Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 33. ALPCO Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Enzo Life Sciences Corporate Information, Head Office, and Major Competitors
Table 35. Enzo Life Sciences Major Business
Table 36. Enzo Life Sciences Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 37. Enzo Life Sciences Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. BioMérieux Corporate Information, Head Office, and Major Competitors
Table 39. BioMérieux Major Business
Table 40. BioMérieux Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 41. BioMérieux Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. EMD Millipore Corporate Information, Head Office, and Major Competitors
Table 43. EMD Millipore Major Business
Table 44. EMD Millipore Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 45. EMD Millipore Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. BioLegend Corporate Information, Head Office, and Major Competitors
Table 47. BioLegend Major Business
Table 48. BioLegend Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 49. BioLegend Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. LOEWE Biochemica Corporate Information, Head Office, and Major Competitors
Table 51. LOEWE Biochemica Major Business
Table 52. LOEWE Biochemica Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 53. LOEWE Biochemica Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Mercodia Corporate Information, Head Office, and Major Competitors
Table 55. Mercodia Major Business
Table 56. Mercodia Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 57. Mercodia Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Cusabio Corporate Information, Head Office, and Major Competitors
Table 59. Cusabio Major Business
Table 60. Cusabio Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 61. Cusabio Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Shanghai Kehua Bio-engineering Corporate Information, Head Office, and Major Competitors
Table 63. Shanghai Kehua Bio-engineering Major Business
Table 64. Shanghai Kehua Bio-engineering Enzyme-Linked Immunosorbent Assay (ELISA) Product and Solutions
Table 65. Shanghai Kehua Bio-engineering Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million) by Players (2019-2021)
Table 67. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Share by Players (2019-2021)
Table 68. Breakdown of Enzyme-Linked Immunosorbent Assay (ELISA) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 69. Enzyme-Linked Immunosorbent Assay (ELISA) Players Head Office, Products and Services Provided
Table 70. Enzyme-Linked Immunosorbent Assay (ELISA) Mergers & Acquisitions in the Past Five Years
Table 71. Enzyme-Linked Immunosorbent Assay (ELISA) New Entrants and Expansion Plans
Table 72. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million) by Type (2016-2021)
Table 73. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Share by Type (2016-2021)
Table 74. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Forecast by Type (2021-2026)
Table 75. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Application (2016-2021)
Table 76. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Forecast by Application (2021-2026)
Table 77. North America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Type (2016-2021) & (USD Million)
Table 78. North America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Type (2021-2026) & (USD Million)
Table 79. North America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Application (2016-2021) & (USD Million)
Table 80. North America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Application (2021-2026) & (USD Million)
Table 81. North America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Country (2016-2021) & (USD Million)
Table 82. North America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Country (2021-2026) & (USD Million)
Table 83. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Type (2016-2021) & (USD Million)
Table 84. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Type (2021-2026) & (USD Million)
Table 85. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Application (2016-2021) & (USD Million)
Table 86. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Application (2021-2026) & (USD Million)
Table 87. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Country (2016-2021) & (USD Million)
Table 88. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Country (2021-2026) & (USD Million)
Table 89. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Type (2016-2021) & (USD Million)
Table 90. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Type (2021-2026) & (USD Million)
Table 91. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Application (2016-2021) & (USD Million)
Table 92. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Application (2021-2026) & (USD Million)
Table 93. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Region (2016-2021) & (USD Million)
Table 94. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Region (2021-2026) & (USD Million)
Table 95. South America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Type (2016-2021) & (USD Million)
Table 96. South America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Type (2021-2026) & (USD Million)
Table 97. South America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Application (2016-2021) & (USD Million)
Table 98. South America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Application (2021-2026) & (USD Million)
Table 99. South America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Country (2016-2021) & (USD Million)
Table 100. South America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Country (2021-2026) & (USD Million)
Table 101. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Type (2016-2021) & (USD Million)
Table 102. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Type (2021-2026) & (USD Million)
Table 103. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Application (2016-2021) & (USD Million)
Table 104. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Application (2021-2026) & (USD Million)
Table 105. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Country (2016-2021) & (USD Million)
Table 106. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Enzyme-Linked Immunosorbent Assay (ELISA) Picture
Figure 2. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Type in 2020
Figure 3. Sandwich ELISA
Figure 4. Indirect ELISA
Figure 5. Competitive ELISA
Figure 6. Others
Figure 7. Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Application in 2020
Figure 8. Immunology Picture
Figure 9. Inflammation Picture
Figure 10. Infectious Diseases Picture
Figure 11. Cancer Picture
Figure 12. Protein Quantitation Picture
Figure 13. Others Picture
Figure 14. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 15. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Forecast (2016-2026) & (USD Million)
Figure 16. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Region (2016-2026)
Figure 17. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Region in 2020
Figure 18. North America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. South America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Middle East and Africa Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. Enzyme-Linked Immunosorbent Assay (ELISA) Market Drivers
Figure 24. Enzyme-Linked Immunosorbent Assay (ELISA) Market Restraints
Figure 25. Enzyme-Linked Immunosorbent Assay (ELISA) Market Trends
Figure 26. R&D Systems Recent Developments and Future Plans
Figure 27. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 28. Ortho Clinical Diagnostics Recent Developments and Future Plans
Figure 29. BD Biosciences Recent Developments and Future Plans
Figure 30. ZEUS Scientific Recent Developments and Future Plans
Figure 31. Bio-Rad Laboratories Recent Developments and Future Plans
Figure 32. ALPCO Recent Developments and Future Plans
Figure 33. Enzo Life Sciences Recent Developments and Future Plans
Figure 34. BioMérieux Recent Developments and Future Plans
Figure 35. EMD Millipore Recent Developments and Future Plans
Figure 36. BioLegend Recent Developments and Future Plans
Figure 37. LOEWE Biochemica Recent Developments and Future Plans
Figure 38. Mercodia Recent Developments and Future Plans
Figure 39. Cusabio Recent Developments and Future Plans
Figure 40. Shanghai Kehua Bio-engineering Recent Developments and Future Plans
Figure 41. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Share by Players in 2020
Figure 42. Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 43. Global Top 3 Players Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share in 2020
Figure 44. Global Top 10 Players Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share in 2020
Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 46. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Share by Type in 2020
Figure 47. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Share Forecast by Type (2021-2026)
Figure 48. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Share by Application in 2020
Figure 49. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Share Forecast by Application (2021-2026)
Figure 50. North America Enzyme-Linked Immunosorbent Assay (ELISA) Sales Market Share by Type (2016-2026)
Figure 51. North America Enzyme-Linked Immunosorbent Assay (ELISA) Sales Market Share by Application (2016-2026)
Figure 52. North America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Country (2016-2026)
Figure 53. United States Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Canada Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Mexico Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Sales Market Share by Type (2016-2026)
Figure 57. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Sales Market Share by Application (2016-2026)
Figure 58. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Country (2016-2026)
Figure 59. Germany Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. France Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. United Kingdom Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Russia Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Italy Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Sales Market Share by Type (2016-2026)
Figure 65. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Sales Market Share by Application (2016-2026)
Figure 66. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Region (2016-2026)
Figure 67. China Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Japan Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. South Korea Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. India Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Southeast Asia Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Australia Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. South America Enzyme-Linked Immunosorbent Assay (ELISA) Sales Market Share by Type (2016-2026)
Figure 74. South America Enzyme-Linked Immunosorbent Assay (ELISA) Sales Market Share by Application (2016-2026)
Figure 75. South America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Country (2016-2026)
Figure 76. Brazil Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Argentina Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Middle East and Africa Enzyme-Linked Immunosorbent Assay (ELISA) Sales Market Share by Type (2016-2026)
Figure 79. Middle East and Africa Enzyme-Linked Immunosorbent Assay (ELISA) Sales Market Share by Application (2016-2026)
Figure 80. Middle East and Africa Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Country (2016-2026)
Figure 81. Turkey Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Saudi Arabia Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. UAE Enzyme-Linked Immunosorbent Assay (ELISA) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. Methodology
Figure 85. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

R&D Systems
Thermo Fisher Scientific
Ortho Clinical Diagnostics
BD Biosciences
ZEUS Scientific
Bio-Rad Laboratories
ALPCO
Enzo Life Sciences
BioMérieux
EMD Millipore
BioLegend
LOEWE Biochemica
Mercodia
Cusabio
Shanghai Kehua Bio-engineering
jiaGou

Add To Cart

gouMai

Buy Now